• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail
-

GRN No. 592

β-glucanase from Bacillus subtilis

Intended Use: For use as a processing aid in brewing and potable alcohol production.
Basis: Scientific procedures
Notifier: Danisco US Inc., 925 Page Mill Road, Palo Alto, CA
Date of filing: Aug 6, 2015
GRAS Notice (releasable information): GRN 592 (in PDF) (926 kB)
Date of closure: Oct 7, 2015
FDA's Letter: FDA has no questions
-
-